NEW DELHI: Clinical trials of the first H1N1 vaccine to be used on Indians from mid-February will start on Wednesday.
Three medical institutes in Delhi, Chandigarh and Pune will test the H1N1 vaccine made by French vaccine manufacturer Sanofi Pasteur in a three-week bridging study on 100 Indians.
The Indian Council of Medical Research (ICMR) wants to be sure that the vaccine, tried and tested in foreign countries, is safe for use on the Indian population.
India is importing 1.5 million doses of this single-shot vaccine by February 15 for use on frontline healthcare workers.